Planning/in-life/histology/reporting will be several months. On the plus side we know IMP761 crosses to cyno from the efficacy modeling that feels forever ago. For ethical and cost considerations my hope is rodent proves sufficient as a species model. If all goes well first in human next year. I wouldn’t expect full tox package data until first half next year.
Planning/in-life/histology/reporting will be several months. On...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 32.0¢ | 31.0¢ | $306.8K | 972.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 178587 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 44597 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |